Hikma raises drug sales outlook as profit jumps on pandemic demand

13Views

August 7, 2020

Hikma Pharmaceuticals Plc raised the annual sales outlook for two of its biggest divisions on Friday and reported higher first-half profit, as hospitals and distributors stocked up on critical medicines during the COVID-19 pandemic.

The company’s largest unit, which supplies needle-based drugs primarily to hospitals, posted double-digit growth in revenue, driven by demand for products to treat patients infected with the coronavirus in the United States and Europe.

Hikma said it expects 2020 revenue from the injectables business to be between $950 million and $980 million, compared with its previous forecast of growth in the low to mid-single digits.

It also raised the revenue outlook for its generics division to a range of $720 million to $760 million, from $700 million to $750 million.

Hikma produces generic treatments including anaesthetics, pain medications, sedatives, neuromuscular blocking agents and anti-infectives. It also supplies the steroidal drug dexamethasone – touted as a possible new treatment for COVID-19 infections.

The drugmaker said it had not seen any hit to its supply chain from the pandemic and that its manufacturing sites had remained open.

Also Watch

“Kids Learn Faster in Mother Tongue,” Says PM Narendra Modi On The New Education Policy

Its core operating profit rose 15% year-on-year to $284 million and Hikma raised its interim dividend by 2 cents to 16 cents per share.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Array
(
[videos] => Array
(
[0] => Array
(
[id] => 5f2d510859a51412a277ce36
[youtube_id] => ShuyiHHOpvo
Hikma raises drug sales outlook as profit jumps on pandemic demand => “Kids Learn Faster in Mother Tongue,” Says PM Narendra Modi On The New Education Policy
)

[1] => Array
(
[id] => 5f2d4c91fbcc0112a8a3c6eb
[youtube_id] => KqnGZOMvzVg
Hikma raises drug sales outlook as profit jumps on pandemic demand => Sushant Death Probe: Rhea Fails To Answer ED’s Questions, Says Doesn’t Remember Details | CNN News18
)

)

[query] => https://pubstack.nw18.com/pubsync/v1/api/videos/recommended?source=n18english&channels=5d95e6c378c2f2492e2148a2,5d95e6c278c2f2492e214884,5d96f74de3f5f312274ca307&categories=5d95e6d7340a9e4981b2e10a&publish_min=2020-08-04T13:11:04.000Z&publish_max=2020-08-07T13:11:04.000Z&sort_by=date-relevance&order_by=0&limit=2
)

Hikma raises drug sales outlook as profit jumps on pandemic demand

Also Watch

Speak Your Mind

LEAVE A REPLY Cancel reply

Get in Touch

Recommend for You

Oh hi there It’s nice to meet you.

Subscribe and receive our weekly newsletter packed with awesome articles that really matters to you!

You might also like

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

About Us

Follow Us

Support Us & Be a Patreon

Add QNewsHub to your Homescreen!

Oh hi there
It’s nice to meet you.